NS5B HVC polymerase inhibitors
US6727267B2 · kind B2 · utility
32Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2001 |
| Grant date | Apr 27, 2004 |
| Priority date | — |
| Expiry date | Apr 5, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D207/48
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided that are useful in the treatment and prevention of certain viral infections and associated diseases. In particular, the compounds of the invention inhibit the activity of a viral RNA polymerase. The subject methods are particularly useful in the treatment of diseases causes by hepatitis C virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.